[
    [
        {
            "time": "",
            "original_text": "【兴证海外医药】港股新股报告合集之欧康维视（1477.HK）：中国眼科创新药物领先企业",
            "features": {
                "keywords": [
                    "兴证海外医药",
                    "港股",
                    "新股",
                    "欧康维视",
                    "1477.HK",
                    "中国",
                    "眼科",
                    "创新药物",
                    "领先企业"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【兴证海外医药】港股新股报告合集之欧康维视（1477.HK）：中国眼科创新药物领先企业",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]